Medical devices, healthcare technology and the business of care
510(k) clearance · K261622

Philips Avent Natural Care Hands-free Wearable Electric Breast Pump (Model: SCF593/52, SCF593/62); Philips Avent Natural Care Warming Hands-free Wearable Electric Breast Pump (Model: SCF594/52, SCF594/62)

Philips Consumer Lifestyle B.V. · Decision date Sep 3, 2026

MEDTECHLEDGER EXPLANATIONK261622

What did the FDA decide?

FDA recorded a substantially equivalent (SESE) decision on 2026-09-03 for K261622, a traditional 510(k) received 05/15/2026 and reviewed under regulation 884.5160 with product code HGX in the Obstetrics/Gynecology panel. The submission covers the Philips Avent Natural Care Hands-free Wearable Electric Breast Pump (models SCF593/52 and SCF593/62) and the Philips Avent Natural Care Warming Hands-free Wearable Electric Breast Pump (models SCF594/52 and SCF594/62), classified as Pump, Breast, Powered.

The applicant is Philips Consumer Lifestyle B.V. of Drachten, NL; the correspondent is Philips Personal Health, a subsidiary of Philips North America, LLC, Stamford, CT. SESE means the devices were cleared as substantially equivalent to a predicate, not granted PMA approval. The page states the review was not by third party, was not a combination product, and no Predetermined Change Control Plan was authorized. The predicate device, the specific differences from it, and any testing or clinical evidence are not shown in this record.

Because the record omits the predicate and the basis for equivalence, no conclusion about comparative performance or safety can be drawn here; those details would sit in the underlying 510(k) documents.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Obstetrics/Gynecology
Decision date
Sep 3, 2026
FDA decision documents: 510(k) Premarket Notification

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K261622
Regulatory pathway
510(k) premarket notification
Product code
HGX
Decision code
SESE
Decision date
Sep 3, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Pump, Breast, Powered.

Product code
HGX
FDA device class
2

FDA decision timeline

  1. K261622 received

    Application receipt date recorded by FDA.

  2. K261622 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code HGX

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Philips Consumer Lifestyle B.V.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Drachten

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records